glp-1 diarrhea law office in louisiana 🎉A new approach to weight loss! 🎉 medications are changing the landscape of weight management. Join us for FREE classes to learn more about these medicines., ➡️This week's class:, ⏰SATURDAY MAR GLP-1 RA Lawsuit - Shreveport

MULTI BENEFITS: Curbs cravings and supports appetite suppression, balanced sugar levels, metabolism boost and improved immunity and mood

Learn about Mounjaro and menopause: can weight loss injections help with menopausal weight gain

Includes Probiotics and Plant-Based Fiber: Formulated with Akkermansia muciniphila, Lactobacillus reuteri, and resistant potato starch, this supplement offers a combination of probiotics and prebiotic fiber often included in immune support supplement routines

Can GLP1s be used safely in advanced CKD and dialysis

Dietitian support included....

From oral formulations to agonist combinations, from muscle preservation to indication expansion, the question remains: who will be the next company to bring a GLP-1-based therapeutic to the market?The 2nd GLP-1-Based Therapeutics Summit is your dedicated platform for leaders and decision-makers to connect, collaborate, and continue to transform healthcare as we know it through the development of GLP-1s.URLs:Tickets: Developer Pricing* - Conference + 2 Workshops : USD 4197.00,Drug Developer Pricing* - Conference + 1 Workshop: USD 3598.00,Drug Developer Pricing* - Conference Only: USD 2999.00,Academic Pricing** - Conference + 2 Workshops: USD 3597.00,Academic Pricing** - Conference + 1 Workshop Only: USD 3098.00,Academic Pricing** - Conference Only: USD 2599.00,Solution Provider Pricing - Conference + 2 Workshops: USD 5097.00,Solution Provider Pricing - Conference + 1 Workshop: USD 4398.00,Solution Provider Pricing - Conference Only: USD 3699.00Speakers: Adam Bell, Vice President, Translational Medicine and Regulatory Affairs, Neuraly, Andrew Young, Chief Scientific and Medical Officer, I2O Therapeutics, Belle van Rosmalen, Director - Incretin Outcomes, Eli Lilly and Co., Damian Bialonczyk, Global Medical Lead - Metabolism, Roche, David Glass, Vice President - Research, Regeneron, Elisa Araldi, Professor, University of Parma, Hong Chen, Director - Search and Evaluation, Novo Nordisk, Jason Mastaitis, Sr